A CME/MOC-Accredited Live Webinar Series in Conjunction with the IASLC 2024 World Conference on Lung Cancer

Presented by Research To Practice

Live Webcast Series | September 10, 11 & 12, 2024

Register or Learn More

This CME/MOC-accredited virtual program is provided by Research To Practice and supported by educational grants from AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Daiichi Sankyo Inc, Genmab US Inc, Gilead Sciences Inc, and Regeneron Pharmaceuticals Inc.

Program Description

This CME/MOC-accredited virtual symposium series moderated by Dr Neil Love has been specifically designed to accomplish two distinct objectives: 1) review new and relevant research findings and 2) illustrate the real-work applicability of these and other data sets through the discussion of challenging cases. The agenda for both webinars will be divided into two modules, which will each employ an identical format. To begin, each faculty will participate in an approximately 10-minute moderated presentation during which they will review relevant clinical research findings including new data sets emerging during the 2024 WCLC. Following the completion of each presentation, Dr Love will then ask the faculty members to present and discuss cases of patients from their practices that illustrate how the data sets and information presented can be applied in practical treatment settings. Panel discussion surrounding these cases will then ensue. To increase engagement, webinar participants will be invited to submit questions of their own via our interactive Zoom platform.

PART 1 – EGFR Mutation-Positive Non-Small Cell Lung Cancer
Tuesday, September 10th | 9:00 PM – 10:00 PM Eastern Time (6:00 PM – 7:00 PM Pacific Time)

Register or Learn More

This CME/MOC-accredited virtual program is provided by Research To Practice and supported by educational grants from Black Diamond Therapeutics Inc, Daiichi Sankyo Inc and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC

Faculty

Joshua K Sabari, MD
Attending Physician
Thoracic Medical Oncology
Assistant Professor of Medicine
NYU Langone Health
Perlmutter Cancer Center
New York, New York

Helena Yu, MD
Medical Oncologist
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, New York

Moderator

Neil Love, MD
Research To Practice
Miami, Florida

---

PART 2 – Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
Wednesday, September 11^th | 5:00 PM – 6:00 PM Eastern Time (2:00 PM – 3:00 PM Pacific Time)

Register or Learn More

This CME/MOC-accredited virtual program is provided by Research To Practice and supported by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, and Lilly.

Faculty

Ibiayi Dagogo-Jack, MD
Assistant Professor of Medicine
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts

Corey J Langer, MD
Director of Thoracic Oncology
Abramson Cancer Center
Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Moderator

Neil Love, MD
Research To Practice
Miami, Florida

---

PART 3 – Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
Thursday, September 12^th | 5:00 PM – 6:00 PM Eastern Time (2:00 PM – 3:00 PM Pacific Time)

Register or Learn More

Faculty

Edward B Garon, MD, MS
Professor
Director, Thoracic Oncology Program
Director, Signal Transduction and Therapeutics Research Program
David Geffen School of Medicine at UCLA
Jonsson Comprehensive Cancer Center
Los Angeles, California

Luis Paz-Ares, MD, PhD
Chair of the Medical Oncology Department
at the Hospital Universitario 12 de Octubre
Associate Professor at the
Universidad Complutense
Head of the Lung Cancer Unit
at the National Oncology Research Center
Madrid, Spain

Moderator

Neil Love, MD
Research To Practice
Miami, Florida

__________________________________________________
Additional sessions will be announced. For more information, please visit our website: http://www.researchtopractice.com/Webinars/WCLC2024.